Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism
NAD+ Metabolism Generates a Metabolic Vulnerability in Endocrine-Resistant Metastatic [PMID: 37170651] Laboratory literature summary: NAD+ Metabolism Generates a Metabolic Vulnerability in Endocrine-Resistant Metastatic Breast Tumors in research models
How can GLP-1s reduce addictive behaviors
But its experimental, and there are currently no robust clinical trials supporting its safety or efficacy in this context
US$ 21.51
US$ 20.25
US$ 29.43
US$ 29.04
US$ 22.71
US$ 27.91
US$ 25.48
US$ 26.15
US$ 21.86
